Neutralization heterogeneity of United Kingdom and South-African SARS-CoV-2 variants in BNT162b2-vaccinated or convalescent COVID-19 healthcare workers - Institut Pierre Louis d'Epidémiologie et de Santé Publique Accéder directement au contenu
Article Dans Une Revue Clinical Infectious Diseases Année : 2021

Neutralization heterogeneity of United Kingdom and South-African SARS-CoV-2 variants in BNT162b2-vaccinated or convalescent COVID-19 healthcare workers

Résumé

There are concerns about neutralizing antibodies (NAbs) potency against SARS-CoV-2 variants. Despite decreased NAb titers elicited by BNT162b2-vaccine against VOC202012/01 and 501Y.V2 strains, 28/29 healthcare workers (HCW) had a NAb titer ≥1:10. In contrast, six months after COVID-19 mild-forms, only 9/15 (60%) of HCW displayed detectable NAbs against 501Y.V2 strain.
Fichier principal
Vignette du fichier
Marot et al. - 2021 - Neutralization heterogeneity of United Kingdom and.pdf (287.13 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03280729 , version 1 (07-07-2021)

Identifiants

Citer

Stéphane Marot, Isabelle Malet, Valentin Leducq, Basma Abdi, Elisa Teyssou, et al.. Neutralization heterogeneity of United Kingdom and South-African SARS-CoV-2 variants in BNT162b2-vaccinated or convalescent COVID-19 healthcare workers. Clinical Infectious Diseases, 2021, ⟨10.1093/cid/ciab492⟩. ⟨hal-03280729⟩
26 Consultations
30 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More